Pune, Oct. 12
PHARMA packaging research and solutions company Bilcare has unveiled its clinical services facility here.
Dr Christoph Moeschli, Head, Clinical Packaging of Novartis Pharma AG Switzerland, inaugurated the new facility.
Talking to presspersons, Mr Mohan Bhandari, Chairman and Managing Director, Bilcare, said this facility would support pharma companies in packaging and distributing their clinical supplies and integrate their global clinical trial requirements efficiently.
The facility has been constructed near its existing unit at Rajgurunagar near Pune. Mr Bhandari said the core of the global clinical service included manufacturing, packaging, randomisation, storage and distribution, returns and destruction of clinical supplies.
He said the company was looking at a topline revenue of $25 million for the first year from these services. Mr Bhandari said the pharma spend on a global basis was about $500 billion, of which research and development took up about $100 billion. Out of this R&D spend, clinical trials accounted for $25 billion and clinical services about $3 billion. This was the market that Bilcare was targeting, he said.
Novartis Pharma is the first client for clinical services of the new facility, he said.
Mr Bhandari said Bilcare had made its first strategic acquisition outside the country by acquiring in July ProClinical (now called Bilcare Inc in the US) along with the distribution centres in major regions of the world. ProClinical is an established pharma research and clinical packaging services business in Pennsylvania.
He noted that this acquisition provided Bilcare an entry into the US pharma market. The 14-acre site is US Food and Drug Administration-approved and is also licensed by the Drug Enforcement Agency for handling controlled substances.